The role of membrane-bound LBP,endotoxin aggregates,and the MaxiK channel in LPS-induced cell activation

Abstract

We have previously shown in patch-clamp experiments on excised outside-out cytoplasmic membrane patches from human macrophages that the activation of a high-conductance Ca²⁺ - and voltage-dependent potassium channel, the MaxiK channel, is an early step in LPS-induced transmembrane signal transduction in macrophages. MaxiK can be activated by agonistically active LPS, and activation can be completely inhibited by LPS antagonists (e.g. synthetic compound 406) and by anti-CD14 antibodies. Furthermore, by inhibiting MaxiK with the specific MaxiK blocker paxilline, we could show that activation of MaxiK is essential for LPS-induced cytokine production. As shown by RT-PCR, blockade of MaxiK by paxilline also inhibits induction of the mRNA of TNF-α and IL-6. This observation together with the fact that all patch-clamp experiments were done on excised outside-out patches reveal that MaxiK activation is an early step in cell activation by endotoxins. Thus, since cells lacking TLR4 on their surface can also not be activated to produce cytokines, these data allow the conclusion that TLR4 and MaxiK are both essential for activation by LPS and may form a co-operative signaling complex. We have also shown that LBP not only exists as a soluble acute-phase serum protein, but is also incorporated as a transmembrane protein (mLBP) in the cytoplasmic membrane of MNC; in this configuration, it is obviously involved in the binding of endotoxin and its transfer to the transmembrane signaling proteins finally triggering cell activation. Complexation of soluble LBP and LPS in the serum prior to binding of LPS to mLBP, in contrast, leads to neutralization of LPS. Here, we provide evidence from fluorescence resonance energy transfer spectroscopy that endotoxin aggregates are intercalated into reconstituted membranes by mLBP. In addition, cell culture assays and patch-clamp experiments demonstrate that endotoxin activates macrophages and the MaxiK channel in the aggregated, but not in the monomeric, state at similar concentrations.

References

Schumann RR , Leong SR , Flaggs GW et al. Structure and function of lipopolysaccharide binding protein . Science 1990; 249: 1429—1431.

Wright SD , Ramos RA , Tobias PS , Ulevitch RJ , Mathison JC CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990; 249: 1431—1433.

Chow JC , Young DW , Golenbock DT , Christ WJ , Gusovsky F. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction . J Biol Chem 1999; 274: 10689—10692.

el Samalouti VT , Schletter J. , Chyla I. et al. Identification of the 80-kDa LPS-binding protein (LMP80) as decay-accelerating factor (DAF, CD55). FEMS Immunol Med Microbiol 1999; 23: 259—269.

Denlinger LC , Fisette PL , Sommer JA et al. Cutting edge: the nucleotide receptor P2X7 contains multiple protein- and lipid-interaction motifs including a potential binding site for bacterial lipopolysaccharide. J Immunol 200 1; 167: 1871—1876.

Frey EA , Miller DS , Jahr TG et al. Soluble CD14 participates in the response of cells to lipopolysaccharide . J Exp Med 1992; 176: 1665—1671.

Cohen J. TREM-1 in sepsis. Lancet 2001; 358: 776—778.

Takayama K. , Mitchell DH , Din ZZ , Mukerjee P. , Li C. , Coleman DL Monomeric Re lipopolysaccharide from Escherichia coli is more active than the aggregated form in the Limulus amebocyte lysate assay and in inducing Egr-1 mRNA in murine peritoneal macrophages. J Biol Chem 1994; 269: 2241—2244.

Shnyra A. , Hultenby K. , Lindberg AA Role of the physical state of Salmonella lipopolysaccharide in expression of biological and endotoxic properties. Infect Immun 1993; 61: 5351—5360.

10.

Velucchi M. , Rustici A. , Porro M. Molecular requirements of peptide structures binding the lipid-A region of bacterial endotoxins. In: Brown F. (ed) Vaccines 94. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 1994; 141—146.

11.

Hailman E. , Lichenstein HS , Wurfel MM et al. Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14. J Exp Med 1994; 179: 269—277.

12.

Schromm AB , Lien E. , Henneke P. et al. Molecular genetic analysis of 25pA an endotoxin non-responder mutant cell line: a point mutation in a conserved region of MD-2 abolishes endotoxin-induced signaling. J Exp Med 2001 ; 194: 79—88.

13.

Becker S. , Warren MK , Haskill S. Colony-stimulating factor-induced monocyte survival and differentiation into macrophages in serum-free cultures. J Immunol 1987; 139: 3703—3709.

14.

Wiese A. , Seydel U. Electrophysiological measurements on reconstituted outer membranes. Methods Mol Biol 2000; 145: 355—370.

15.

Gutsmann T. , Haberer N. , Seydel U. , Wiese A. Interaction between lipopolysaccharide (LPS), LPS-binding protein (LBP), and planar membranes. Biol Chem 2001; 382: 425—434.

16.

Struck DK , Hoekstra D. , Pagano RE Use of resonance energy transfer to monitor membrane fusion. Biochemistry 1981; 20: 4093—4099.

17.

Blunck R. , Scheel O. , Müller M. , Brandenburg K. , Seitzer U. , Seydel U. New insights into endotoxin-induced activation of macrophages: involvement of a K+ channel in transmembrane signaling. J Immunol 2000; 166: 1009—1015.

18.

Gutsmann T. , Muller M. , Carroll SF , MacKenzie RC , Wiese A. , Seydel U. Dual role of lipopolysaccharide (LPS)-binding protein in neutralization of LPS and enhancement of LPS-induced activation of mononuclear cells. Infect Immun 2001; 69: 6942—6950.

19.

Brandenburg K. , Seydel U. , Schromm AB , Loppnow H. , Koch Mhj , Rietschel ET Conformation of lipid A, the endotoxic center of bacterial lipopolysaccharide. J Endotoxin Res 1996; 3: 173—178.